Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Expires:November 30, 2011
Estimated average burden hours per response...0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
NEHRA JOHN M
  2. Issuer Name and Ticker or Trading Symbol
DAVITA HEALTHCARE PARTNERS INC. [DVA]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director_____ 10% Owner
_____ Officer (give title below)_____ Other (specify below)
(Last)
(First)
(Middle)
C/O DAVITA HEALTHCARE PARTNERS INC., 2000 16TH STREET
3. Date of Earliest Transaction (Month/Day/Year)
11/06/2012
(Street)

DENVER, CO 80202
4. If Amendment, Date Original Filed(Month/Day/Year)
6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock 11/06/2012   S   5,000 D $ 115.432 (1) 56,572 D  
Common Stock 11/07/2012   S   10,000 D $ 113.5421 (2) 46,572 D  

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(Month/Day/Year)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares

Reporting Owners

Reporting Owner Name / AddressRelationships
 Director 10% Owner Officer Other
NEHRA JOHN M
C/O DAVITA HEALTHCARE PARTNERS INC.
2000 16TH STREET
DENVER, CO 80202
  X      

Signatures

 /s/ Kim M. Rivera Attorney-in-Fact  11/08/2012
**Signature of Reporting PersonDate

Explanation of Responses:

*If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)The range of prices for the sale of these shares was $115.41 - $115.46. The filer undertakes to provide staff, the issuer or a security holder full information regarding the number of shares sold at each separate price.
(2)The range of prices for the sale of these shares was $112.90 - $114.33. The filer undertakes to provide staff, the issuer or a security holder full information regarding the number of shares sold at each separate price.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.
rrd322851_364984.html
POWER OF ATTORNEY

	The undersigned, John M. Nehra (the "Filer"), hereby constitutes and appoints each of Kim M. Rivera, James K. Hilger, and Jeffrey L. Miller, any of them signing singly and with full power of substitution, as Filer's true and lawful attorneys-in-fact (the "Attorney in Fact") to:

	1.	prepare, execute in Filer's name and behalf, and submit to the U.S. Securities and Exchange Commission (the "SEC") a Form ID, including any amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling Filer to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or any rule or regulation of the SEC;

      2.	execute for and on behalf of Filer, in Filer's capacity as an executive officer of DaVita Inc. (the "Company"), Forms 3, 4 and 5, including any amendments thereto (the "Forms"), in accordance with the Exchange Act, or any rule or regulation of the SEC;

	3.	do and perform any and all acts for and on behalf of Filer which may be necessary or desirable to complete the execution of any Forms, and timely file them with the SEC and any stock exchange or similar authority; and

	4.	take any other action of any type whatsoever in connection with the foregoing which, in the opinion of the Attorney-in-Fact, may be of benefit to, in the best interest of, or legally required by, Filer, it being understood that the documents executed by such Attorney-in-Fact on behalf of Filer pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such Attorney-in-Fact may approve in their discretion.

      The undersigned hereby grants to Attorney-in-Fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the Filer might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such Attorney-in-Fact, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted.

	Filer acknowledges that Attorney-in-Fact, in serving in such capacity at the request of Filer, is not assuming any of Filer's responsibilities to comply with Section 16 of the Exchange Act.

      This Power of Attorney shall be effective on the date set forth below and shall continue in full force and effect until the date on which Filer is no longer required to file Forms 3, 4 and 5 with respect to Filer's holdings of and transactions in securities issued by the Company, unless earlier revoked by Filer in a signed writing delivered to Attorney-in-Fact.

	IN WITNESS WHEREOF, Filer has caused this Power of Attorney to be executed as of the 15th day of April, 2010.

							/s/ John M. Nehra _________________
							John M. Nehra


Q:\Dept\SCGLegal\Securities\Section 16\Powers of Attorney\2010\POA - Nehra (4-5-2010).doc